Epirubicin-induced oxidative DNA damage and evidence for its repair in lymphocytes of cancer patients who are undergoing chemotherapy

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 882-885

  Olinski, Ryszard ^a   Jaruga, Pawel ^a   Foksinski, Marek ^a   Bialkowski, Karol ^a   Tujakowski, Jerzy ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Oncology Centre Bydgoszcz   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DNA BASE; EPIRUBICIN; FLUOROURACIL; FREE RADICAL; GYRASE INHIBITOR; METHOTREXATE; VINBLASTINE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA DAMAGE; DNA MODIFICATION; DNA REPAIR; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; OVARY CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; SARCOMA; SECOND CANCER; THYROID CANCER;

EID: 0030864214     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.882     Document Type: Article

References (39)

1. Mazué, G., M. Iatropoulos, A. Imandi, S. Castellino, M. Brughera, A. Podest, P. Della Torre, and D. Moneta. Anthracyclines. A review of general and special toxicity studies. Int. J. Oncology 7:713-726 (1995).
2. Anderson, R. D., and N. A. Berger. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat. Res. 309:109-142 (1994).
3. Myers, C. Anthracyclines, in Cancer Chemotherapy, and Biological Response Modifiers (H. M. Pinedo, D. L. Longo, and B. A. Chabner, eds.). Elsevier Science Publishers B.V., Amsterdam, 43-49 (1992).
4. Olson, R. D., and P. S. Mushlin. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4:3076-3086 (1990).
5. Doroshow, J. H. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res. 43:4543-4551 (1983).
6. Feig, D. I., T. M. Reid, and L. A. Loeb. Reactive oxygen species in tumorigenesis. Cancer Res. 54(7 Suppl.):1890s-1894s (1994).
7. Feig, D. I., L. C. Sowers, and L. A. Loeb. Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc. Natl. Acad. Sci. USA 91:6609-6613 (1994).
8. Grollman, A. P., and M. Moriya. Mutagenesis by 8-oxoguanine. an enemy within. Trends Genet. 9:246-249 (1993).
9. Purmal, A. A., Y. W. Kow, and S. S. Wallace. Major oxidative products of cytosine, 5-hydroxycytosine and 5-hydroxyuracil, exhibit sequence context-dependent mispairing in vitro. Nucleic Acids Res. 22:72-78 (1994).
10. Akman, S. A., J. H. Doroshow, T. G. Burke, and M. Dizdaroglu. DNA base modifications induced in isolated human chromatin by NADH dehydrogenase-catalyzed reduction of doxorubicin. Biochemistry 31:3500-3506 (1992).
11. Dizdaroglu, M. Chemical determination of oxidative DNA damage by gas chromatography-mass spectrometry. Methods Enzymol. 234:3-16 (1994).
12. Gajewski, E., G. Rao, Z. Nackerdien, and M. Dizdaroglu. Modification of DNA bases in mammalian chromatin by radiation-generated free radicals. Biochemistry 29:7876-7882 (1990).
13. Djuric, Z., L. K. Heilbrun, B. A. Reading, A. Boomer, F. A. Valeriote, and S. Marti Effects of a low-fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. J. Natl. Cancer Inst. 83:766-769 (1991).
14. Plosker, G. L., and D. Faulds. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs 45:788-856 (1993).
15. Jaruga, P., T. H. Zastawny, J. Skokowski, M. Dizdaroglu, and R. Olinski. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 341:59-64 (1994).
16. Olinski, R., T. H. Zastawny, J. Budzbon, J. Skokowski, W. Zegarski, and M. Dizdaroglu. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 193:193-198 (1992).
17. Olinski R., T. H. Zastawny, M. Foksinski, W. Windorbska, P. Jaruga, and M. Dizdaroglu. DNA base damage in lymphocytes of cancer patients undergoing radiation therapy. Cancer Lett. 106:207-215 (1996).
18. Malins, D. C., and R. Haimanot. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 51:5430-5432 (1991).
19. Malisza, K. L., and B. B. Hasinoff. Production of Hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the xanthine oxidase/hypoxanthine system. Arch. Biochem. Biophys. 321:51-60 (1995).
20. Carmine, T. C., P. Evans, G. Bruchelt, R. Evans, R. Handgretinger, D. Niethammer, and B. Halliwell. Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. Cancer Lett. 94:219-226 (1995).
21. Gordon, L. I., S. G. Brown, M. S. Tallman, A. W. Rademaker, S. A. Weitzman, H. M. Lazarus, C. H. Kelley, C. Mangan, H. Rubin, R. M. Fox, R. J. Creger, and J. N. Winter. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Radical Biol. Med. 18:383-389 (1995).
22. Meneghini, R., M. S. Benfato, C. R. Bertoncini, H. Carvalho, S. A. Gurgueira, R. L. Robalinho, H. D. Teixeira, C. M. A. Wendel, and A. L. T. O. Nascimento. Iron homeostasis and oxidative DNA damage. Cancer J. 8:109-113 (1995).
23. Kyrtopoulos, S. A. Variability in DNA repair and individual susceptibility to genotoxins. Clin. Chem. 41:1848-1853 (1995).
24. Strauss, B., P. Hanawalt, and J. Swenberg. Risk assessment in environmental carcinogenesis-meeting report. Cancer Res. 54:5493-5496 (1994).
25. Faure, H., C. Coudray, M. Mousseau, V. Ducros, T. Douki, F. Bianchini, J. Cadet, and A. Favier. 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Radical Biol. Med. 20:979-983 (1996).
26. Ames, B. N., and R. L. Saul. Oxidative DNA damage as related to cancer and aging. Prog. Clin. Biol. Res. 209A:11-26 (1986).
27. Hollstein, M. C., P. Brooks, S. Linn, and B. N. Ames. Hydroxymethyl uracil DNA glycosylase in mammalian cells. Proc. Natl. Acad. Sic. USA 81:4003-4007 (1984).
28. Loft, S., A. Fisher-Nielsen, I. B. Jeding, K. Vistisen, and H. Poulsen. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative damage. J. Toxicol. Environ. Health 40:391-404 (1993).
29. Demple, B., and L. Harrison. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 63:915-948 (1994).
30. Jaruga P., and M. Dizdaroglu. Repair of products of oxidative DNA base damage in human cells. Nucleic Acids Res. 24:1389-1394 (1996).
31. Ferguson, L. R., and W. A. Denny. Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis? Mutat. Res. 331:1-26 (1995).
32. Lajtha, L. G. Which are the leukaemic cells? Blood Cells 7:45-62 (1981).
33. Kasprzak, K., B. A. Divan, J. M. Rice, M. Misra, C. W. Riggs, R. Olinski, and M. Dizdaroglu. Nickel(II)-mediated oxidative DNA base damage in renal and hepatic chromatin of pregnant rats and their fetuses. Possible relevance to carcinogenesis. Chem. Res. Toxicol. 5:809-815 (1992).
34. Wei, L., H. Wei, and K. Frenkel. Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage. Carcinogenesis 14:841-847 (1993).
35. Toyokuni, S., T. Mori, and M. Dizdaroglu. DNA base modifications in renal chromatin of Wistar rats treated with renal carcinogen, ferric nitrilotriacetate. Int. J. Cancer 57:123-128 (1994).
36. Wood, M. L., M. Dizdaroglu, E. Gajewski, and J. M. Essigmann. Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry 29:7024-7032 (1990).
37. Moriya, M., C. Ou, V. Bodeoudi, F. Johson, M. Takeshita, and A. P. Grollman. Site-specific mutagenesis using a gapped duplex vector: a study of translesion synthesis past 8-oxodeoxyguanosine in E. coli. Mutat. Res. 254:281-288 (1991).
38. Cheng, K. C., D. S. Cahill, H. Kasai, S. Nishimura, and L. A. Loeb. 8-hydroxyguanosine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem. 267:166-172 (1992).
39. Kamiya, H., H. Miura, N. Murata-Kamiya, H. Ishikawa, T. Sakagushi, H. Inoue, T. Sasaki, C. Masutani, F. Hanaoka, S. Nishimura, and E. Ohtsuka. 8-Hydroxyadenine (7,8-dihydro-8-oxoadenine) induces misincorporation in in vitro DNA synthesis and mutations in NIH 3Y3 cells. Nucleic Acids Res. 23:2893-2899 (1995).